Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors

BMC Proceedings

Poster Presentation

Gustavo P Amarante-Mendes¹  Daniel D de Carvalho¹  Barbara P Mello¹  Antonio HJFM Campos²  Fernando A Soares² 

[1] Department of Immunology, Sao Paulo University, São Paulo, Brazil;Department of Pathologic Anatomy, AC Camargo Hospital, São Paulo, SP, Brazil;

关键词: Retinoic Acid;    Chronic Myeloid Leukemia;    Acute Promyelocytic Leukemia;    Chronic Myeloid Leukemia Patient;    Chronic Myeloid Leukemia Cell;   

DOI  :  10.1186/1753-6561-7-S2-P10

来源: Springer

【 授权许可】

Unknown   
© Mello et al; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.